Sinovac COVID vaccine approved for children aged 6-11 in Indonesia
Advertisement
Jakarta: Indonesia has approved the Sinovac Biotech Covid-19 vaccine for children aged 6-11, its food and drug agency said on Monday, following the U.S. Food and Drug Administration's approval of the Pfizer/BioNTech vaccine for younger kids.
Until Monday, Indonesia had cleared the Chinese-made Sinovac vaccine only for people aged 12 and above, of which it has the most amount in its arsenal with over 200 million doses.
Penny K. Lukito, chief of the agency (BPOM), told a news conference that the approval was "pleasant news. We're sure that children's vaccination is an urgent thing, especially now that...in-person learning has started."
The approval comes as Indonesia is two months into its trial of in-person learning. Health minister Budi Gunadi Sadikin said that COVID-19 cases found in schools during this period "are relatively low."
Siti Nadia Tarmizi, a health ministry official, said that vaccinations for children may start early next year, as it awaits further recommendation from Indonesia's paediatric association and more vaccine shots.
Chile has also approved the Sinovac vaccine for younger children.
Indonesia was Asia's COVID-19 epicentre in July, with the Delta variant driving up infections and deaths though both counts have plummeted.
Infections among children aged 0-18 make up for 13% of total cases, government data shows.
Indonesia has vaccinated about 27% of its population of 270 million.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.